Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 163,097 | 579,745 | 437,022 | 317,641 | 131,501 |
| Depreciation Amortization | 106,932 | 380,293 | 278,030 | 181,275 | 88,815 |
| Income taxes - deferred | 7,183 | -81,555 | -40,366 | -18,172 | 5,015 |
| Accounts receivable | -54,703 | -70,701 | -57,723 | -40,999 | -6,642 |
| Other Working Capital | 19,007 | -79,760 | -141,203 | -99,213 | -15,633 |
| Other Operating Activity | 125,469 | 290,732 | 199,013 | 123,815 | 59,273 |
| Operating Cash Flow | $366,985 | $1,018,754 | $674,773 | $464,347 | $262,329 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 83,516 | N/A | N/A | N/A | N/A |
| PPE Investments | -86,031 | -267,437 | -158,938 | -117,178 | -37,332 |
| Net Acquisitions | -25,000 | -95,789 | -92,289 | -42,289 | -42,289 |
| Purchase Of Investment | -440,880 | -2,968,916 | -2,221,040 | -1,884,189 | -891,436 |
| Sale Of Investment | 917,972 | 3,253,779 | 2,802,330 | 2,440,368 | 803,675 |
| Other Investing Activity | 0 | -208,209 | 0 | 0 | 0 |
| Investing Cash Flow | $449,577 | $-286,572 | $330,063 | $396,712 | $-167,382 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -70,126 | -5,399 | -10,215 | 7,491 | 3 |
| Debt Issued | 986,876 | N/A | 1,512,296 | N/A | N/A |
| Debt Repayment | -1,500,000 | -6,563 | -18,605 | -10,266 | -3,703 |
| Common Stock Issued | 28,311 | 489,180 | 247,436 | 81,748 | 22,908 |
| Common Stock Repurchased | -240,219 | -2,991,184 | -2,991,183 | N/A | N/A |
| Other Financing Activity | 7,626 | 1,780,627 | 31,400 | 9,840 | 5,193 |
| Financing Cash Flow | $-787,532 | $-733,339 | $-1,228,871 | $88,813 | $24,401 |
| Exchange Rate Effect | -193 | -558 | -16 | 332 | 215 |
| Beginning Cash Position | 659,662 | 661,377 | 661,377 | 661,377 | 661,377 |
| End Cash Position | 688,499 | 659,662 | 437,326 | 1,611,581 | 780,940 |
| Net Cash Flow | $28,837 | $-1,715 | $-224,051 | $950,204 | $119,563 |
| Free Cash Flow | |||||
| Operating Cash Flow | 366,985 | 1,018,754 | 674,773 | 464,347 | 262,329 |
| Capital Expenditure | -86,031 | -284,106 | -175,750 | -117,178 | -37,332 |
| Free Cash Flow | 280,954 | 734,648 | 499,023 | 347,169 | 224,997 |